How Does the EMA Collaborate with Other Regulatory Bodies?
The EMA collaborates with other regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the World Health Organization (WHO), to harmonize regulatory standards and expedite the approval of new cancer treatments. This collaboration helps to avoid duplication of efforts, streamline processes, and bring innovative therapies to patients more quickly.
